|
|
|
|
|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
|
Fig. 6. Evidence for other targets of EDEN-BP than XSu(H) in the segmentation
process. (A-F) Embryos were injected in one blastomere at the two-cell stage
with 2 fmol of XSu(H)1 mRNA. They were allowed to develop to stage 28 (A,B) or
stage 26 (C-F), and then stained with the 12/101 monoclonal antibody (A,B), or
stained with the ESR5 (C,D) or X-Delta2 (E,F) probes. (A,C,E) Injected sides,
and (B,D,F) non-injected sides of the same embryos. Asterisks highlight
successive somites in B. TBD, tailbud domain; S1 to S4, somitomeres 1 to 4.
(G) Embryos were injected with 25ng of each E-Mo, and 0, 1, 2.5 or 5 ng of
each X-Mo as indicated. The graph represents the percentage of abnormally
segmented embryos, normalized to 100% for the embryos injected with E-Mo only.
The total number of embryos examined for each of these conditions is indicated
above each bar.
|
